DA-034 30 Pill - pink round, 9mm
Generic Name: aripiprazole
Pill with imprint DA-034 30 is Pink, Round and has been identified as Abilify MyCite 30 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd.
Abilify MyCite is used in the treatment of Bipolar Disorder; Depression; Schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Abilify MyCite 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DA-034 30
Abilify MyCite
- Generic Name
- aripiprazole
- Imprint
- DA-034 30
- Strength
- 30 mg
- Color
- Pink
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Otsuka Pharmaceutical Co., Ltd
- National Drug Code (NDC)
- 59148-0034
- Inactive Ingredients
-
corn starch,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
ferric oxide yellow,
ferric oxide red,
FD&C Blue No. 2,
aluminum oxide,
aluminum,
magnesium,
silicon,
silicon dioxide,
titanium,
triethyl citrate
Note: Inactive ingredients may vary.
More about Abilify MyCite (aripiprazole)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
Patient resources
- Abilify MyCite Maintenance Kit oral with sensor drug information
- Abilify MyCite Starter Kit oral with sensor
- Abilify Mycite (Advanced Reading)
- Abilify MyCite
Other brands
Aristada, Abilify Asimtufii, Aristada Initio, Abilify Discmelt
Professional resources
Other brands
Aristada, Abilify Asimtufii, Aristada Initio
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
